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Conditional testing of multiple variants associated
with bone mineral density in the FLNB gene
region suggests that they represent a single
association signal
Benjamin H Mullin1,2,3*, Cyril Mamotte2, Richard L Prince1,3, Tim D Spector4, Frank Dudbridge5 and Scott G Wilson1,3,4
Abstract
Background: Low bone mineral density (BMD) is a primary risk factor for osteoporosis and is a highly heritable
trait, but appears to be influenced by many genes. Genome-wide linkage studies have highlighted the chromosomal
region 3p14-p22 as a quantitative trait locus for BMD (LOD 1.1 - 3.5). The FLNB gene, which is thought to have a role
in cytoskeletal actin dynamics, is located within this chromosomal region and presents as a strong candidate for BMD
regulation. We have previously identified significant associations between four SNPs in the FLNB gene and BMD
in women. We have also previously identified associations between five SNPs located 5' of the transcription start
site (TSS) and in intron 1 of the FLNB gene and expression of FLNB mRNA in osteoblasts in vitro. The latter five
SNPs were genotyped in this study to test for association with BMD parameters in a family-based population of
769 Caucasian women.
Results: Using FBAT, significant associations were seen for femoral neck BMD Z-score with the SNPs rs11720285,
rs11130605 and rs9809315 (P = 0.004 – 0.043). These three SNPs were also found to be significantly associated
with total hip BMD Z-score (P = 0.014 – 0.026). We then combined the genotype data for these three SNPs with
the four SNPs we previously identified as associated with BMD and performed a conditional analysis to determine
whether they represent multiple independent associations with BMD. The results from this analysis suggested
that these variants represent a single association signal.
Conclusions: The SNPs identified in our studies as associated with BMD appear to be part of a single association
signal between the FLNB gene and BMD in our data. FLNB is one of several genes located in 3p14-p22 that has
been identified as significantly associated with BMD in Caucasian women.
Keywords: Bone mineral density, Filamin B, SNP, Osteoporosis
Background
Postmenopausal osteoporosis is a systemic bone disease
that is characterised by low bone mass and disturbed
micro architecture of bone tissue, resulting in decreased
bone strength and a corresponding increase in the risk
of fracture [1]. Bone mass peaks in early adult life, but
declines in postmenopausal women due to a reduction
in oestrogen production which has direct effects on
bone as well as calcium handling by the intestine and
renal system [2]. In addition to these effects and
environmental factors, there is a strong genetic effect
on peak bone mass, bone loss and fracture rates in
postmenopausal women [3]. Twin and family studies
suggest that 50-85% of the variance in peak bone
mass [4-7] and 25-68% of the variance in osteoporotic
fracture is heritable [8-10].
The whole genome linkage scanning approach has
identified multiple quantitative trait loci (QTL) for
bone mineral density (BMD) [11], strongly suggesting
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that genetic influence for the phenotype is mediated
through multiple genes. The 3p14-p22 region of the
human genome has been identified as a QTL for BMD
in multiple genome-wide linkage studies (LOD 1.1 - 3.5)
[12-15]. The Filamin B (FLNB) gene, which is thought
to have a role in cytoskeletal actin dynamics [16], is
located within this chromosomal region and presents
as a strong candidate for BMD regulation. Mutations
within the FLNB gene have been implicated in a variety
of genetic disorders characterised by skeletal malformation,
some of which include: spondylocarpotarsal synostosis
syndrome [17-19], Larsen syndrome [18,20], atelosteo-
genesis types I and III [18,21] and boomerang dysplasia
[22]. Associations have also been identified between
polymorphism in FLNB and human stature variation in
a genome-wide association study [23].
We have previously identified significant associations
between four single nucleotide polymorphisms (SNPs)
in the FLNB gene and BMD in Caucasian women [24].
Two of these SNPs were identified as being in moderate
to strong linkage disequilibrium (LD) with five other
SNPs located either 5′ of the transcription start site
(TSS) or in intron 1 of the gene, all five of which were
significantly associated with expression of FLNB mRNA
in 96 human osteoblast cell lines [24]. Based on this
data, we decided to perform a follow up to our previous
study [24] and examine these five SNPs in relation to BMD
parameters in a family-based population of Caucasian
women. Genotype data for any significant variants
would then be combined with the genotype data for the
four FLNB SNPs previously associated with BMD [24]
in a conditional analysis to determine whether multiple
loci exist in the FLNB gene that are independently
associated with BMD.
Results
The demographic and morphometric characteristics of
the population are detailed in Table 1. There are a large
number of osteoporotic individuals in this population,
resulting in a negative mean BMD Z-score observed at
each site studied. All 5 SNPs genotyped were in Hardy-
Weinberg equilibrium as determined using a χ2 test. LD
analysis revealed that none of the 5 SNPs genotyped
were in LD of r2 > 0.8 with each other (Figure 1). An
additional LD analysis revealed that one of the 5 SNPs
genotyped in this study, rs839230, is in LD of r2 > 0.8
with rs704529 which was genotyped in our previous
study [24]. However, none of the other 4 SNPs genotyped
in this study were in LD of r2 > 0.8 with any of the
other SNPs genotyped in our previous study [24]. The
chromosomal position and allele distribution of the 5
SNPs genotyped in this study and the 13 SNPs genotyped
in our previous study [24] is detailed in Table 2.
Locus specific analyses: effects of individual SNP
genotypes on phenotypic data
Using FBAT, significant associations were seen for
femoral neck BMD Z-score with the SNPs rs11720285,
rs11130605 and rs9809315 (P = 0.005, 0.043 and 0.004
respectively). These three SNPs were also found to be
significantly associated with total hip BMD Z-score (P =
0.014, 0.026 and 0.022 respectively). No significant associ-
ations were observed between any of the 5 SNPs examined
and spine BMD Z-score. After correction of the data
for testing 5 SNPs across 3 anatomical sites, the significant
association between rs9809315 and femoral neck BMD Z-
score was maintained (P = 0.028). Estimates of the additive
genetic effect suggest that the minor alleles at rs11720285
(C), rs11130605 (T) and rs9809315 (T) are associated
with an increased BMD Z-score at both the total hip
and femoral neck sites (Table 3).
Haplotype analysis
A 3-SNP haplotype analysis was carried out using
rs11720285, rs11130605 and rs9809315 to determine
whether haplotypes of the LD blocks tagged by each
SNP would prove to be more significantly associated
with femoral neck or total hip BMD Z-score than in
the individual SNP analysis. Six haplotypes with a fre-
quency greater than 4% in the population were identified.
Significant associations were observed with femoral neck
BMD Z-score only (Table 4), although the level of signifi-
cance did not surpass that observed in the individual
SNP analysis for this phenotype. The CTT haplotype
was found to have a strong positive influence on femoral
neck BMD Z-score.
Bioinformatics analysis
The SNP rs11130605 has been identified by the HapMap
Genome Browser [25] (release #27) as being in complete
LD with the SNPs rs7631741 and rs7634753 in the CEU
population (Utah residents with Northern and Western
European ancestry). These two SNPs were therefore
included in the bioinformatics analysis.
Table 1 Demographics and bone density of the
population studied
Variable Population mean
Age (years) 54.2 ± 12.7 (769)
Weight (Kg) 62.7 ± 11.3 (699)
Total hip DXA BMD (mg/cm2) 801 ± 136 (760)
Total hip BMD Z-score −0.4 ± 1.0 (760)
Femoral neck DXA BMD (mg/cm2) 700 ± 133 (749)
Femoral neck BMD Z-score −0.4 ± 1.1 (749)
Spine L1-L4 DXA BMD (mg/cm2) 855 ± 158 (767)
Spine BMD Z-score −0.7 ± 1.3 (767)
Results are given as mean ± SD (number of measurements).
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The rs11130605 polymorphism has an F-SNP score of
0.101 as it is located in a potential regulatory region.
rs7634753 has an F-SNP score of 0.242 with the more
common C allele resulting in the loss of an STRE site
and the gain of N-Myc and USF sites. The rs9809315
polymorphism also has an F-SNP score of 0.242 and is
located in a potential regulatory region, with the more
common C allele resulting in loss of HSF, Dfd, CdxA
and GCN4 sites. No functional information currently
exists for rs11720285 and rs7631741 in F-SNP, so these
variants were analysed using HaploReg [26]. Using this
resource, the more common A allele at rs11720285 was
found to result in the loss of a Sox_9 site with the gain
of Evi-1_2 and Hoxa4 sites. The more common T allele
at rs7631741 was found to result in a gain of a HMG-
IY_2 site.
Conditional analysis
The genotype data for rs11720285, rs11130605 and
rs9809315 was combined with that for the four other
SNPs from the FLNB gene that we previously identified
as associated with BMD [24] for a conditional analysis.
These four SNPs are rs7637505, rs9822918, rs2177153
and rs2001972. Out of these seven SNPs, rs2177153
demonstrated the strongest associations with BMD
and was therefore used as the conditioning marker.
Once the data had been conditioned on rs2177153, no
significant associations with femoral neck or total hip
BMD Z-score were observed for any of the other six
SNPs (P = 0.32 – 0.93).
Discussion
We previously identified 5 SNPs from the 5′ region of
the FLNB gene that were strongly associated with
expression levels of FLNB mRNA [24], 3 of which have
been shown here to be significantly associated with
age-adjusted total hip and femoral neck BMD in Cau-
casian women. The minor allele at each of these 3 SNP
sites was associated with an increased BMD Z-score in
this study and a reduced level of FLNB mRNA in our
previous study [24]. However, when the genotype data
for these 3 SNPs was combined with that for 4 FLNB
SNPs previously identified as associated with BMD and
conditioned on the most significantly associated SNP,
Figure 1 LD analysis of the 5 SNPs genotyped in this study.
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none of the associations remained significant. This sug-
gests that these variants represent a single association
signal between the FLNB gene and BMD in this study
population. This is not the first time that common vari-
ation within a gene that has previously been identified
as underlying a rare monogenetic form of osteoporosis
and/or high bone mass has been implicated in BMD
regulation, other examples including the SOST, CLCN7
and LRP5 genes [27].
Although rs2177153 demonstrated the most significant
associations with BMD in the study population combined
dataset [24], we cannot be sure that this is the quantitative
Table 2 Position and allele distribution of all FLNB variants genotyped in this and our previous study
SNP Chromosome position* Location* Major/minor allele Minor allele frequency (%)
rs11720285 57961370 5' of TSS A/C 25.1
rs7637505† 57968393 5' of TSS A/T 29.4
rs6445938† 57974822 5' of TSS A/G 23.1
rs11130605 57989169 5' of TSS C/T 39.2
rs6798382† 57991811 5' of TSS G/A 28.6
rs4681772† 57992512 5' of TSS A/G 32.1
rs1658351† 58013573 Intron 1 A/G 33.5
rs1718481 58025903 Intron 1 G/A 42.7
rs704529† 58036651 Intron 1 A/G 36.2
rs839230 58036792 Intron 1 G/A 36.2
rs9809315 58050265 Intron 1 C/T 30.2
rs9822918† 58057684 Intron 1 C/A 44.6
rs2177153† 58092346 Intron 11 A/G 31.8
rs1131356† 58109162 Exon 21, Asp > Asn G/A 22.9
rs12632456† 58118555 Exon 26, Val > Met G/A 23.2
rs2001972† 58123249 Intron 28 C/A 37.6
rs4284952† 58126223 Intron 29 C/A 34.6
rs4234386† 58150433 Intron 43 G/A 24.4
*Relative to GenBank reference sequence NM_001457, Genome Build 37.5.
†Variant genotyped in our previous study [24].
Table 3 Additive value of minor allele for FLNB variants associated with BMD Z-score in this and our previous study
SNP BMD Z-score phenotype Additive value of minor allele P
rs11720285 Femoral neck + 0.306 (366) 0.03
Total hip + 0.274 (373) 0.053
rs7637505† Femoral neck + 0.287 (422) 0.031
Total hip + 0.262 (434) 0.033
rs11130605 Femoral neck + 0.241 (575) 0.045
Total hip + 0.268 (592) 0.03
rs9809315 Femoral neck + 0.304 (435) 0.014
Total hip + 0.254 (448) 0.045
rs9822918† Femoral neck + 0.397 (650) 0.002
Total hip + 0.414 (668) 0.002
rs2177153† Femoral neck + 0.537 (459) 0.0004
Total hip + 0.443 (474) 0.001
rs2001972† Femoral neck + 0.254 (547) 0.043
Total hip + 0.264 (563) 0.041
Results are given as additive effect on the trait of the minor allele relative to the more common allele (number of alleles included in analysis), derived from
UNPHASED v3.1.5.
†Variant genotyped in our previous study [24].
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trait nucleotide responsible for the associations seen.
Of the three SNPs identified in this study as associated
with BMD, rs11130605 demonstrated the most significant
associations with FLNB mRNA expression levels in our
previous study [24]. This could suggest that the SNP
rs11130605, or another SNP in very strong LD with it,
is the causal variant responsible for the associations
seen. It is interesting that F-SNP identified rs11130605
and rs9809315 as being located in potential regulatory
regions. These SNPs had F-SNP scores of 0.101 and
0.242 respectively, with the median F-SNP score for a
neutral SNP thought to be around 0.176 [28]. The SNP
rs7634753 also had an F-SNP score of 0.242, with the
common allele predicted to cause the gain of binding
sites for the transcription factors N-Myc and USF. Both
of these transcription factors have been shown to have
a role in bone, with N-Myc having been implicated in
the development of the limb bones in mice [29,30] and
USF having been shown to have a role in the process of
receptor activator of nuclear factor kappa-B ligand
(RANKL) induced tartrate-resistant acid phosphatase
(TRAP) transcription during osteoclast differentiation
[31]. Variation at rs11720285 was found to alter Hoxa4
and Sox_9 sites. Hoxa4 may have a role in vertebral
development in mice [32], while mutations in the human
SOX9 gene have been found to cause campomelic
dysplasia [33], a disease characterised by shortness and
bowing of long tubular bones, hypoplastic scapulae and
narrow iliac wings. There are two non-synonymous
coding changes within the FLNB gene that have a minor
allele frequency > 1% in Caucasians, both of which were
genotyped in our previous study [24] and neither of
which demonstrated significant associations with BMD
parameters.
A recent study published by Li et al. [34] analysed
seven SNPs from the FLNB gene, including the SNPs
rs9822918 and rs2177153 genotyped in our previous
study [24], for association with BMD parameters in a
case–control population of 1,080 Chinese females, 533
of whom were postmenopausal. The authors were not
able to replicate the associations that we observed
between rs2177153 and BMD, which is probably due to
the fact that this SNP had a minor allele frequency of
only 0.02 in their population compared to a mean of
0.32 in our study. However, they did observe significant
associations between rs9822918 and BMD at the total
hip [34]. Although providing more support of a role for
the FLNB gene in osteoporosis, comparisons with this
study and our previous study must be done with caution
due to differences in study design as well as differences
in the ethnicity of the study subjects.
In addition to the evidence suggesting a role for the
human FLNB gene in bone development [17-22], there
is increasing evidence to suggest that the murine Flnb
gene also has a role in bone. Flnb expression has been
detected in vertebral bodies obtained from mouse embryos,
and it has been suggested that the gene plays a role in
vertebral segmentation, joint formation and endochondral
ossification [18]. Zhou et al. [35] generated mice with
a targeted disruption of the Flnb gene and observed
impaired development of the microvasculature and
skeletal systems in Flnb-deficient embryos, few of which
reached term. Those that were born were very small
and had severe skeletal malformations including scoliotic
and kyphotic spines, fusion of vertebral bodies, lack of
intervertebral discs and reduced hyaline matrix in the
extremities, thorax and vertebrae [35]. Another study
published by Lu et al. [36] found that Flnb-deficient
mice presented with shortened distal limbs and small
body size, abnormal spinal curvatures, dysmorphic facial/
calvarial bones and develop fusion of the ribs and
vetebrae, which appeared to be caused by a delay in
chondrocyte development.
Over 70 binding partners have been identified to date
for the filamin proteins [37,38]. They are thought to have
a role in stabilising the actin cytoskeleton, providing a link
between the actin network and the cellular membranes,
and mediating interactions between actin and trans-
membrane receptors [16]. Filamins act to maintain the
structural integrity of cells by crosslinking the actin
cytoskeleton into 3D structures [16,39]. The ability of
filamin proteins to bind actin at their N-terminus and
form tail-to-tail homodimers at their C-terminus allows
them to create the orthogonal actin networks and bundles
that result in gelation [40]. It has also been proposed
that filamins are important during foetal development,
regulating the communication between extracellular
signals and the cytoskeleton to guide migration of cells
into the correct anatomical sites [16].
FLNB is the third gene from the 3p14-p22 region of
the human genome that we have found to be associated
with BMD in Caucasian women, the other two being
ARHGEF3 [41] and RHOA [42]. Interestingly, all three
of these genes appear to have a role in cytoskeletal
Table 4 Haplotype analysis and additive value of each haplotype relevant to femoral neck BMD Z-score
BMD Z-score phenotype Haplotype (rs11720285, rs11130605, rs9809315)
ACC allele CTT allele ATC allele ACT allele ATT allele CTC allele P
Femoral neck 0 (769) + 0.72 (260) + 0.184 (148) + 0.044 (83) - 0.442 (82) - 0.164 (76) 0.005
Results are given as additive effect on the trait of each haplotype relative to the most common haplotype (number of alleles included in the analysis), derived from
UNPHASED v3.1.5.
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dynamics and actin polymerisation [16,43,44]. It is possible
that more than one gene from this chromosomal region
may be responsible for the linkage observed between
3p14-p22 and BMD. A recently published meta-analysis
of 17 genome-wide association studies identified 56 loci
associated with BMD, including the CTNNB1 gene
located in 3p22.1, and 14 loci associated with risk of
fracture at the genome-wide significance level [27].
Although providing some weak evidence of association
for SNPs in FLNB with BMD, the SNPs analysed here
were not identified in this meta-analysis as associated
with BMD at the genome-wide significance level (P < 5 ×
10-8). The results of the meta-analysis must be treated
with caution though as allele risk modelling suggested
that only 5.8% of the total genetic variance in femoral
neck BMD was accounted for by the genome-wide-
significant SNPs reported in the study [27]. The role of
rare or private variants, functional SNPs or small inser-
tions and deletions that are not well represented by the
genome-wide association study SNP arrays due to weak
LD, may explain the inability of the meta-analysis to
characterise most of the source of the genetic variance.
Conclusions
Polymorphism at rs11720285, rs11130605 and rs9809315,
all of which are located either 5′ of the TSS or in intron 1
of the FLNB gene and have been previously reported to
be associated with FLNB mRNA expression in osteoblasts
in vitro [24], has been identified as significantly associated
with BMD in Caucasian women in this study. The fact
that these SNPs are located in non-coding regions of
the gene and influence mRNA levels indicates that the
associations observed are due to regulatory effects on
the gene. A conditional analysis of the genotype data for
these SNPs combined with those showing associations
with BMD from our previous study [24] suggests a single
association signal between these variants and BMD.
Methods
Subjects
A total of 769 women from 335 families were recruited
in Australia and the UK. This family-based population
included siblings recruited in 1998 for a study of the
genetics of osteoporosis [13] and is the same as the
family-based cohort used in our previous FLNB study
[24] with the inclusion of one additional sibling pair.
Exclusion criteria were applied where possible and included
the presence of bone cancer, hyperparathyroidism, unstable
thyroid disease, long term steroid use (> 5 mg/day for
more than 6 months and presently on therapy), chronic
immobility, rheumatoid arthritis, anorexia nervosa, osteo-
malacia, amenorrhea for > 6 months, premature cessation
of regular menstruation or surgical oophorectomy +/−
HRT (age < 40 yrs), and epilepsy with use of anticonvulsant
medication for > 1 year. All subjects from the study
provided written informed consent and the experimental
protocols were approved by the Sir Charles Gairdner
Group Human Research Ethics Committee and the
St Thomas’ Hospital Research Ethics Committee.
At a clinic visit data including age, height, weight,
medical, gynaecological, and lifestyle data were recorded
and a blood sample collected. Dual energy X-ray ab-
sorptiometry (DXA) BMD was assessed (Hologic Inc.,
Bedford, MA, USA) at the lumbar spine L1-L4 and the
total hip that includes an area from the femoral neck to
just below the lesser trochanter. Within this area the
femoral neck sub-region is widely used in clinical practice
for prediction of fracture propensity and was therefore
also included in the study. Due to the range of ages in
this cohort, BMD data was adjusted for age prior to
analysis by conversion to BMD Z-scores.
Genotyping
Genomic DNA was extracted and purified from EDTA
whole blood obtained from each subject [45]. Genotyping
was performed on genomic DNA using the TaqMan
assay, which utilises fluorogenic 5′ nuclease chemistry,
in 384-well PCR plate format. Using this technique the
genotype call rate was 99.3% and the estimated error
rate was < 0.1%.
SNP selection
5 SNPs located either 5′ of the TSS or in intron 1 of the
FLNB gene were selected for genotyping. These were
selected based on previously published data suggesting
that all five SNPs are significantly associated with
expression of FLNB mRNA in 96 human osteoblast cell
cultures [24].
Statistical analysis
Data from the cohort was analysed using the FBAT
(Family Based Association Tests) software to test for
association within sib-pairs, a method based on the
allelic transmission disequilibrium test [46]. We used a
within-family additive genetic association model and
the empirical variance estimator was used to allow for
prior linkage to the region. Correction for multiple testing
was performed by randomly permuting phenotypes within
sibships and repeating all FBAT tests on the permuted
datasets. The minimum P-values were recorded for 10,000
random reassignments of the data using an automated
script written in Perl. This approach was used to correct
for tests of multiple SNPs within each phenotype, and also
for tests of multiple SNPs across multiple phenotypes.
UNPHASED v3.1.5 was used to estimate the genetic
effect size in this cohort by generating an additive value
as an estimate to how each allele influences the trait
value relative to the most common allele [47]. This
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program was also used to perform a haplotype analysis
and a conditional analysis. Throughout, two-tailed P-
values are reported, with P < 0.05 considered signifi-
cant. LD between the different SNPs was evaluated
using the JLIN software [48].
Bioinformatics analysis
An in silico analysis of SNP targets was performed using
the Functional Single Nucleotide Polymorphism (F-SNP)
database [49], which integrates data from 16 bioinformatics
resources to help identify SNPs that may disrupt functional
genomics regions. Any variants not present in the F-SNP
database were analysed using HaploReg [26], a web-based
tool for exploring annotations of the non-coding genome.
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